水痘ワクチン市場レポート：動向、予測、競合分析 (2031年まで)

世界の水痘ワクチン市場の将来は、病院・診療所市場での機会により有望視されています。世界の水痘ワクチン市場は、2025年から2031年までのCAGRが5.8%で、2031年までに推定49億米ドルに達すると予想されています。この市場の主な促進要因は、世界の予防接種プログラムの増加、水痘ワクチンの使用に対する一般市民の意識の高まり、予防接種プログラムに対する政府の拠出金の増加です。

• Lucintelの予測では、用途別では帯状疱疹が予測期間中に最も高い成長を遂げる見込みです。
• 最終用途別では、病院が予測期間中に高い成長が見込まれます。
• 地域別では、確立されたワクチン接種プログラムの存在と、同地域の人口増加に伴うワクチン接種需要の高まりにより、北米が引き続き最大地域となります。

水痘ワクチン市場の戦略的成長機会

水痘ワクチン市場の成長を加速させるのは、技術の開発、認知度の向上、主要部門での予防接種キャンペーンの増加です。

• 新規市場：新市場は、水痘ワクチン接種プログラムを拡大する上で、多くの成長機会を提供します。市場シェア拡大や世界全体の患者数減少に向けた好条件の創出は、これらの地域における入手しやすさと価格の改善を通じて達成されるであろう。
• 混合ワクチンの開発：水痘を含む混合ワクチンへの投資は、予防接種スケジュールを簡素化し、コンプライアンスを促進します。この戦略は、免疫を統合し、ワクチン接種プロセスを簡素化することで、マーケティングアピールを向上させることができます。
• ワクチン製剤の強化：ワクチンの副作用が少なく、免疫期間が長い、より優れた新しい製剤の開発には成長機会があります。このような開発により、水痘ワクチンの受容が促進され、使用量が増加することが期待されます。
• 定期予防接種スケジュールへの組み込み：水痘ワクチン接種を小児期の予防接種計画に組み込むことで、小児の接種率を維持することができ、アウトブレイクを回避することができます。この方法は、予防接種率を高め、公衆衛生全体を改善することにつながります。
• 公衆衛生意識向上プログラムと教育：公衆衛生と水痘予防接種の重要性に関する意識に焦点を当てることは、成長を促進する可能性があります。予防接種のリスクとベネフィットについて人々に知らせることを目的とした教育プログラムは、ワクチンの摂取率と接種率の向上につながります。

このような機会は、アクセスの改善、ワクチンの技術的進歩、公衆衛生分野での可能性の拡大を通じて、水痘ワクチン市場を形成しています。

水痘ワクチン市場促進要因・課題

水痘ワクチン市場のプレーヤーは、技術の進歩、経済要因、規制など様々な影響、促進要因・課題にさらされています。これらの要素を理解することは、市場情勢をナビゲートするために不可欠です。

水痘ワクチン市場を牽引する要因は以下の通り：

• 技術の進歩：ワクチン接種技術は、より新しい処方や組み合わせなど大きな変化を遂げ、売上を押し上げています。こうした改良はワクチンの効率性と安全性を高め、より高い受容率と公衆衛生の向上につながっています。
• 人々の意識の高まり：一般市民の意識の高まりにより、水痘予防接種の需要が増加しています。その結果、公衆衛生キャンペーンや教育的介入によってワクチン接種率が向上し、水痘の患者が減少しています。
• ワクチンアクセスの拡大：市場成長の原動力となったのは、十分なサービスを受けていない新興市場における水痘ワクチンへのアクセス拡大です。入手しやすく手頃な価格のワクチンの登場は、世界の水痘罹患率の低下と予防接種率の向上につながりました。

水痘ワクチン市場における課題は以下の通り：

• 規制上の課題：規制上の課題：ワクチン製品の認定や安全性に関する厳格なガイドラインを満たすことが障害となることが多いです。市場参入や製品開拓に必要な規則の遵守は、スケジュールや支出に影響します。
• 経済的制約：経済的要因は、経済状況の変化によるワクチン製造コストの変動や値ごろ感など、市場力学に影響を与える可能性があります。コストと品質のバランスを保つことは、競争力のある事業拡大のために重要です。

これらの促進要因・課題はすべて、製品開発、市場開拓、規制遵守に影響するため、水痘ワクチン市場を形成します。

目次

第1章 エグゼクティブサマリー

第2章 世界の水痘ワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の水痘ワクチン市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の水痘ワクチン市場：製品種類別
  • 一価水痘ワクチン
  • 混合水痘ワクチン
• 世界の水痘ワクチン市場：用途別
  • おたふく風邪
  • 麻疹
  • 風疹
  • 水痘予防接種
  • 帯状疱疹
  • 免疫
  • 水痘ワクチン接種
• 世界の水痘ワクチン市場：最終用途別
  • 病院
  • クリニック
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の水痘ワクチン市場：地域別
• 北米の水痘ワクチン市場
• 欧州の水痘ワクチン市場
• アジア太平洋の水痘ワクチン市場
• その他地域の水痘ワクチン市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の水痘ワクチン市場の成長機会：製品種類別
  • 世界の水痘ワクチン市場の成長機会：用途別
  • 世界の水痘ワクチン市場の成長機会：最終用途別
  • 世界の水痘ワクチン市場の成長機会：地域別
• 世界の水痘ワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の水痘ワクチン市場の生産能力拡大
  • 世界の水痘ワクチン市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

The future of the global chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets. The global chickenpox vaccine market is expected to reach an estimated $4.9 billion by 2031 with a CAGR of 5.8% from 2025 to 2031. The major drivers for this market are the increasing number of vaccination programs worldwide, the rising public awareness of the use of chickenpox vaccines, and the growing government contribution to immunization programs.

• Lucintel forecasts that, within the application category, herpes zoster is expected to witness the highest growth over the forecast period.
• Within the end-use category, the hospital is expected to witness higher growth over the forecast period.
• In terms of regions, North America will remain the largest region due to the presence of a well-established vaccination program and the growing demand for vaccine coverage with an expanding population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Chickenpox Vaccine Market

The market for chickenpox vaccines is witnessing multiple emerging trends that are shaping future vaccination efforts and public health strategies.

• More Emphasis on Combination Vaccines: There is growing interest in combination vaccines that include chickenpox along with other vaccines. This simplification of vaccination schedules and the greater likelihood of adherence will increase overall immunization rates.
• Access to Emerging Markets: Global coverage has increased due to efforts to extend vaccination programs to emerging markets. Better accessibility and affordability have led to higher rates of immunization and fewer cases of chickenpox in previously underserved areas.
• Better Vaccine Formulations: Improvements in vaccine formulations are resulting in more effective vaccines with longer-lasting immunity and fewer side effects. It is expected that these improvements will enhance the performance and safety of vaccines, thus increasing their acceptance and use by a wider population.
• Incorporation into Routine Immunization Schedules: Several countries are incorporating chickenpox vaccination into routine immunization schedules. The intention behind this trend is to ensure uniformity across the board, reducing cases of chickenpox that could lead to outbreaks.
• Emphasis on Public Health Campaigns: Public health campaigns have shifted their focus toward creating awareness about the need for chickenpox vaccination. These campaigns contribute to enlightening people, addressing vaccine hesitancy, and increasing vaccination levels.

These trends are revamping the chickenpox vaccine market through improved vaccine technology, broader access, and heightened public awareness.

Recent Developments in the Chickenpox Vaccine Market

The chickenpox vaccine market is witnessing several key developments that reflect advancements in vaccine technology, increased access, and improved public health initiatives.

• Introduction of Combination Vaccines: New combination vaccines that include chickenpox alongside other childhood vaccines are being introduced. The creation of these new combination vaccines will streamline vaccination schedules, improve compliance rates, and enhance overall vaccination coverage.
• Expansion of Vaccine Access: Initiatives are underway to increase chickenpox vaccine accessibility in underserved and rural areas. This move results from governmental measures and public health campaigns aimed at enhancing immunization coverage while minimizing outbreaks.
• Advancements in Vaccine Formulations: Recent advances in vaccine formulations result in better vaccines with greater efficacy, prolonged protection, and fewer side effects. These enhancements also contribute to improved vaccine performance and increased acceptability.
• Enhanced Public Health Campaigns: Public health campaigns are on the rise that focus on sensitizing the general population about the importance of chickenpox vaccination. Awareness programs like this help educate people, combat hesitancy about vaccinations by providing information, and boost vaccination rates.
• Integration into Routine Immunization: Several countries are incorporating chickenpox vaccination into their routine immunization schedules. The aim is to ensure universal coverage, thus reducing cases of chickenpox and preventing outbreaks.

These developments are advancing the chickenpox vaccine market by improving vaccine technology, increasing access, and enhancing public health efforts.

Strategic Growth Opportunities for Chickenpox Vaccine Market

Accelerating the growth of the chickenpox vaccine market is the development of technology, growing awareness, and increased immunization campaigns in key sectors.

• New Markets: New markets offer plenty of opportunities for growth in expanding chickenpox vaccination programs. Creating favorable conditions for a larger market share and a decrease in overall global cases will be achieved through improvements in accessibility and affordability in these regions.
• Combined Vaccine Development: Investing in combination vaccines that include varicella will simplify immunization schedules and foster compliance. This strategy can improve marketing appeal by consolidating immunities and simplifying the vaccination process.
• Enhanced Vaccine Formulation: Growth opportunities exist in developing better and new formulations with fewer side effects and longer immunity periods for vaccines. It is expected that such developments will promote acceptance and thus increase the use of chickenpox vaccines.
• Embedding Into Routine Immunization Schedules: By integrating chickenpox vaccination into planned childhood immunizations, children's coverage can be maintained, thereby averting outbreaks. This method can lead to higher rates of vaccination and better overall public health.
• Public Health Awareness Programs and Education: Focusing on public health and awareness about the importance of chickenpox vaccination has the potential to drive growth. Education programs aimed at informing people about the risks and benefits of immunizations will lead to increased uptake and coverage for vaccines.

These opportunities have shaped the chickenpox vaccine market by increasing its reach through access improvements, technological advances in vaccines, and expansion of possibilities within public health areas.

Chickenpox Vaccine Market Driver and Challenges

Players in the chickenpox vaccine market are subject to various influences, drivers, and challenges such as technological advancements, economic factors, and regulations. Understanding these elements is vital for navigating the market landscape.

The factors driving the chickenpox vaccine market include:

• Technological Advancements: Vaccination technologies have undergone significant changes, such as newer formulas and combinations, which have boosted sales. These improvements heighten vaccine efficiency and safety, leading to higher acceptance rates and better public health outcomes.
• Increased Public Awareness: There is an increasing demand for chickenpox vaccinations due to heightened awareness among the public. This has resulted in increased vaccination rates through public health campaigns and educational interventions that have reduced cases of chickenpox.
• Expansion of Vaccine Access: The market's growth has been driven by attempts to expand access to chickenpox vaccines in underserved and emerging markets. Improved availability and affordability have led to a decline in the global incidence of chickenpox and enhanced immunization coverage.

Challenges in the chickenpox vaccine market include:

• Regulatory Challenges: Issues arising from meeting strict guidelines governing accreditation for vaccine products and safety often pose obstacles. Compliance with rules needed for market entry or product development affects timelines and expenditures.
• Economic Constraints: Economic factors can influence market dynamics, such as fluctuating vaccine production costs and affordability due to changing economic conditions. Maintaining a cost-quality balance is important for competitive business expansion.

All these drivers and challenges shape the chickenpox vaccine market because they affect product development, market growth, and regulatory compliance.

List of Chickenpox Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chickenpox vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chickenpox vaccine companies profiled in this report include-

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

Chickenpox Vaccine by Segment

The study includes a forecast for the global chickenpox vaccine market by product type, application, end use, and region.

Chickenpox Vaccine Market by Product Type [Analysis by Value from 2019 to 2031]:

• Monovalent Varicella Vaccine
• Combination Varicella Vaccine

Chickenpox Vaccine Market by Application [Analysis by Value from 2019 to 2031]:

• Mumps
• Measles
• Rubella
• Varicella Immunization
• Herpes Zoster
• Immunization
• Chickenpox Vaccination

Chickenpox Vaccine Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Clinics
• Others

Chickenpox Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Chickenpox Vaccine Market

The market for chickenpox vaccines is changing as vaccine technology advances, global vaccination campaigns increase, and awareness of the prevention of chickenpox grows. Recent developments indicate better vaccine formulations, more accessible vaccines, and new public health initiatives aimed at reducing the incidence of chickenpox and its complications.

• United States: In the U.S., there has been progress in varicella vaccines with updated versions that offer improved effectiveness and longer-lasting protection. Better school-based immunization programs and increased vaccine outreach efforts have led to higher vaccination rates and a decrease in outbreaks.
• China: The expansion of access to rural areas and underserved communities has been a key focus for China regarding the distribution of chickenpox vaccines. The government is investing in vaccination programs and public health education to enhance vaccination coverage against chickenpox and control outbreaks.
• Germany: Combination vaccines containing chickenpox and other childhood infections are now being used in Germany. The objective is to minimize the number of shots that children need to receive while increasing adherence. Additionally, Germany is improving its vaccination programs by introducing school mandates and public awareness campaigns.
• India: India's market for chickenpox vaccines is expanding due to an increase in low-cost vaccine availability. Public health campaigns are raising awareness about the significance of immunization, leading to increased uptake, particularly in remote areas where vaccination services are becoming accessible.
• Japan: Japan has made strides in developing better vaccines that provide improved immunity against varicella with fewer side effects. Additionally, Japan aims to include this vaccine in routine immunizations to keep all recipients protected from illness.

Features of the Global Chickenpox Vaccine Market

Market Size Estimates: Chickenpox vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Chickenpox vaccine market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Chickenpox vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the chickenpox vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chickenpox vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the chickenpox vaccine market by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chickenpox Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Chickenpox Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Chickenpox Vaccine Market by Product Type
  • 3.3.1: Monovalent Varicella Vaccine
  • 3.3.2: Combination Varicella Vaccine
• 3.4: Global Chickenpox Vaccine Market by Application
  • 3.4.1: Mumps
  • 3.4.2: Measles
  • 3.4.3: Rubella
  • 3.4.4: Varicella Immunization
  • 3.4.5: Herpes Zoster
  • 3.4.6: Immunization
  • 3.4.7: Chickenpox Vaccination
• 3.5: Global Chickenpox Vaccine Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Chickenpox Vaccine Market by Region
• 4.2: North American Chickenpox Vaccine Market
  • 4.2.1: North American Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.2.2: North American Market by End Use: Hospitals, Clinics, and Others
• 4.3: European Chickenpox Vaccine Market
  • 4.3.1: European Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.3.2: European Market by End Use: Hospitals, Clinics, and Others
• 4.4: APAC Chickenpox Vaccine Market
  • 4.4.1: APAC Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.4.2: APAC Market by End Use: Hospitals, Clinics, and Others
• 4.5: ROW Chickenpox Vaccine Market
  • 4.5.1: ROW Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.5.2: ROW Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Chickenpox Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Chickenpox Vaccine Market by Application
  • 6.1.3: Growth Opportunities for the Global Chickenpox Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Chickenpox Vaccine Market by Region
• 6.2: Emerging Trends in the Global Chickenpox Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Chickenpox Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chickenpox Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bio-Med
• 7.2: GlaxoSmithKline
• 7.3: Emcure Pharmaceuticals
• 7.4: Novo Medi Services
• 7.5: Sanofi
• 7.6: Takeda Pharmaceutical
• 7.7: Changchun BCHT Biotechnology
• 7.8: Green Cross Holdings
• 7.9: Merck
• 7.10: Mitsubishi Chemical Holdings